Financial reports
ARS
2023 FY
Annual report to shareholders
11 Apr 24
10-K/A
2023 FY
Annual report (amended)
11 Apr 24
10-K
2023 FY
Annual report
26 Feb 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
5 May 23
ARS
2022 FY
Annual report to shareholders
3 Apr 23
10-K
2022 FY
Annual report
24 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
Current reports
8-K
Departure of Directors or Certain Officers
20 Feb 24
8-K
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
1 Feb 24
8-K
Departure of Directors or Certain Officers
28 Nov 23
8-K
Merck Announces Third-Quarter 2023 Financial Results
26 Oct 23
8-K
Merck Announces Second-Quarter 2023 Financial Results
1 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
26 May 23
8-K
Other Events
17 May 23
8-K
Merck Announces First-Quarter 2023 Financial Results
27 Apr 23
8-K
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
2 Feb 23
8-K
Merck Announces Third-Quarter 2022 Financial Results
27 Oct 22
Registration and prospectus
S-3ASR
Automatic shelf registration
19 Mar 24
S-3ASR
Automatic shelf registration
19 Mar 24
424B5
Prospectus supplement for primary offering
10 May 23
FWP
Free writing prospectus
8 May 23
424B5
Prospectus supplement for primary offering
8 May 23
424B5
Prospectus supplement for primary offering
9 Dec 21
FWP
Free writing prospectus
8 Dec 21
424B5
Prospectus supplement for primary offering
7 Dec 21
25-NSE
Exchange delisting
15 Oct 21
S-3ASR
Automatic shelf registration
25 Mar 21
Proxies
DEFA14A
Additional proxy soliciting materials
11 Apr 24
DEF 14A
Definitive proxy
11 Apr 24
PX14A6G
Letter to shareholders
1 Apr 24
PX14A6G
Letter to shareholders
27 Mar 24
PX14A6G
Letter to shareholders
18 May 23
PX14A6G
Letter to shareholders
21 Apr 23
PX14A6G
Letter to shareholders
19 Apr 23
PX14A6G
Letter to shareholders
12 Apr 23
DEFA14A
Additional proxy soliciting materials
3 Apr 23
DEF 14A
Definitive proxy
3 Apr 23
Other
SD
Conflict minerals disclosure
22 May 23
SD
Conflict minerals disclosure
20 May 22
SD
Conflict minerals disclosure
21 May 21
SD
Conflict minerals disclosure
21 May 20
SD
Conflict minerals disclosure
23 May 19
SD
Conflict minerals disclosure
29 May 18
SD
Conflict minerals disclosure
25 May 17
NO ACT
No action letter
10 Feb 17
NO ACT
No action letter
9 Feb 17
CERTNYS
Certification of approval for NYSE listing
3 Nov 16
Ownership
3
Betty D Larson
8 Apr 24
4
PETER C WENDELL
29 Mar 24
4
Christine E Seidman
29 Mar 24
4
THOMAS H GLOCER
29 Mar 24
4
Mary Ellen Coe
29 Mar 24
4
Harpoon Therapeutics, Inc.
11 Mar 24
4
Caroline Litchfield
15 Feb 24
4
Robert M Davis
15 Feb 24
144
Notice of proposed sale of securities
14 Feb 24
144
Notice of proposed sale of securities
14 Feb 24